Sarepta Therapeutics’ Duchenne Muscular Dystrophy Gene Therapy Gets FDA Approval
Sarepta Therapeutics' Duchenne Muscular Dystrophy Gene Therapy Gets FDA Approval Barron'sThe Price of First Gene Therapy for Muscular Dystrophy: $3.2 Million The Wall Street JournalCambridge-based Sarepta Therapeutics to charge $3.2M…